Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125638991 | 12563899 | 1 | I | 20160706 | 20160716 | 20160716 | EXP | US-AMGEN-USASL2016089513 | AMGEN | 67.00 | YR | E | F | Y | 0.00000 | 20160716 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125638991 | 12563899 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 30 MG, QD | U | 21688 | 30 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125638991 | 12563899 | 1 | Hyperparathyroidism secondary |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125638991 | 12563899 | OT |
| 125638991 | 12563899 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125638991 | 12563899 | Cellulitis | |
| 125638991 | 12563899 | Cervix carcinoma | |
| 125638991 | 12563899 | Diarrhoea | |
| 125638991 | 12563899 | Heart rate increased | |
| 125638991 | 12563899 | Oxygen saturation decreased | |
| 125638991 | 12563899 | Rheumatoid arthritis | |
| 125638991 | 12563899 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |